Abstract
Patterns of allele-specific expression of H19 and insulin-like growth factor-2 (IGF-2) were examined in tissue obtained from 30 children diagnosed with hepatoblastoma. All informative tumours demonstrated monoallelic expression of H19. In contrast, variable patterns of allele-specific expression of IGF-2 were seen in tumours from children of different ages. © 2000 Cancer Research Campaign
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Davies SM (1993) Maintenance of imprinting at the IGF-2 locus in hepatoblastoma. Cancer Res 53: 4781–4783
Davies SM (1994) Developmental regulation of genomic imprinting of the IGF-2 gene in human liver. Cancer Res 54: 2560–2562
Ekstrom TJ, Cui H, Li X and Ohlsson R (1995) Promoter-specific IGF-2 imprinting status and its plasticity during human liver development. Development 121: 309–316
Glassman ML, de Groot N and Hochberg A (1996) Relaxation of imprinting in carcinogenesis. Cancer Genet Cytogenet 89: 69–73
Hu J-F, Vu TH and Hoffman AR (1996) Promoter-specific modulation of insulin-like growth factor II genomic imprinting by inhibitors of DNA methylation. J Biol Chem 30: 18253–18262
Leisenring WM, Breslow NE, Evans IE, Beckwith JB, Coppes MJ and Grundy P (1994) Increased birthweights of National Wilms’ Tumor Study patients suggest a growth factor excess. Cancer Res 54: 4680–4683
Li X, Adam G, Cui H, Sandstedt B, Ohlsson R and Ekstrom TJ (1995) Expression, promoter usage, and parental imprinting status of insulin-like growth factor 2 (IGF-2) in human hepatoblastoma: uncoupling of IGF-2 and H19 imprinting. Oncogene 11: 221–229
Li X, Cui H, Sandstedt B, Norlinder H, Larsson E and Ekstrom TJ (1996) Expression levels of the insulin-like growth factor-2 gene (IGF-2) in the human liver: developmental relationships of the four promoters. J Endocrinol 149: 117–124
Li X, Non Z, Ekstrom C, Larsson E, Nordlinder H, Hofmann WJ, Trautwein C, Odenthal M, Dienes HP, Ekstrom TJ and Schirmacher P (1997) Disrupted IGF-2 promoter control by silencing of promoter P1 in human hepatocellular carcinoma. Cancer Res 57: 2048–2054
Li X, Gray SG, Flam F, Pietsch T and Ekstrom TJ (1998) Developmental-dependent DNA methylation of the IGF-2 and H19 promoters is correlated to the promoter activities in human liver development. Int J Dev Biol 42: 687–693
Nonomura N, Nishimura K, Miki T, Kanno N, Kojima Y, Yokoyama M and Okuyama A (1997) Loss of imprinting of the insulin-like growth factor 2 gene in renal cell carcinoma. Cancer Res 57: 2575–2577
Ogawa O, Eccles MR, Szeto J, McNoe LA, Yun K, Maw MA, Smith PJ and Reeve AE (1993) Relaxation of insulin-like growth factor 2 gene imprinting implicated in Wilms’ tumour. Nature 362: 749–751
Ohlsson R, Nystrom A, Pfeifer-Ohlsson S, Tohonen V, Hedborg F, Schofield P, Flam F and Ekstrom TJ (1993) IGF-2 is parentally imprinted during human embryogenesis and in the Beckwith–Wiedemann syndrome. Nat Genet 4: 94–97
Rainier S, Johnson LA, Dobry CJ, Ping AJ, Grundy PE and Feinberg AP (1993) Relaxation of imprinted genes in human cancer. Nature 362: 747–749
Rainier S, Dobry CJ and Feinberg AP (1995) Loss of imprinting in hepatoblastoma. Cancer Res 55: 1836–1838
Ross JA, Schmidt PT, Perentesis JP and Davies SM (1999) Genomic imprinting of IGF-2 and H19 in pediatric germ cell tumours. Cancer 85: 1389–1394
Takeda S, Kondo M, Kumada T, Koshikawa T, Ueda R, Nishio M, Osada H, Suzuki H, Nagatake M, Washimi O, Takagi K, Takahashi T, Nakao A and Takahashi T (1996) Allelic-expression imbalance of the insulin-like growth factor 2 gene in hepatocellular carcinoma and underlying disease. Oncogene 12: 1589–1592
Taniguchi T, Schofield AE, Scarlett JL, Morison IM, Sulllivan MJ and Reeve AE (1995) Altered specificity of IGF-2 promoter imprinting during fetal development and onset of Wilms’ tumour. Oncogene 11: 751–756
Uyeno S, Aoki Y, Nata M, Sagisaka K, Kayama T, Yoshimoto T and Ono T (1996) IGF-2 but not H19 shows loss of imprinting in human glioma. Cancer Res 56: 5356–5359
van Gurp RJHLM, Oosterhuis JW, Kalscheuer V, Mariman ECM and Looijenga LHJ (1994) Biallelic expression of the H19 and IGF-2 genes in human testicular germ cell tumors. J Natl Cancer Inst 86: 1070–1075
Vu TH and Hoffman AR (1996) Alterations in the promoter-specific imprinting of the insulin-like growth factor-2 gene in Wilms’ tumor. J Biol Chem 271: 9014–9023
Zemel S, Bartolomei M and Tilghman S (1992) Physical linkage of two mammalian imprinted genes, H19 and IGF-2. Nat Genet 2: 61–65
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Ross, J., Radloff, G. & Davies, S. H19 and IGF-2 allele-specific expression in hepatoblastoma. Br J Cancer 82, 753–756 (2000). https://doi.org/10.1054/bjoc.1999.0992
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1054/bjoc.1999.0992
Keywords
This article is cited by
-
The genetic and epigenetic landscapes of hepatoblastomas
Applied Cancer Research (2017)
-
Involvement of the IGF system in fetal growth and childhood cancer: an overview of potential mechanisms
Cancer Causes & Control (2009)
-
Loss of imprinting of IGF2 correlates with hypermethylation of the H19 differentially methylated region in hepatoblastoma
British Journal of Cancer (2008)
-
Focal overexpression of insulin-like growth factor 2 by hepatocytes and cholangiocytes in viral liver cirrhosis
British Journal of Cancer (2003)
